Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer
about
Integration of omics: more than the sum of its partsPancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parametersGene expression and pathway analysis of effects of the CMAH deactivation on mouse lung, kidney and heart.NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data.A joint analysis of transcriptomic and metabolomic data uncovers enhanced enzyme-metabolite coupling in breast cancer.The complex landscape of pancreatic cancer metabolismDifferential co-expression analysis reveals a novel prognostic gene module in ovarian cancerMetabolic profiles are principally different between cancers of the liver, pancreas and breast.Improved drug therapy: triangulating phenomics with genomics and metabolomics.Analytical methods in untargeted metabolomics: state of the art in 2015.MetaboAnalyst 3.0--making metabolomics more meaningful.Pancreatic cancer stromal biology and therapy.Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors.Accumulation of arachidonic acid-containing phosphatidylinositol at the outer edge of colorectal cancer.Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma.Detecting discordance enrichment among a series of two-sample genome-wide expression data sets.Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients.Comprehensive Dissection of Transcriptome Data and Regulatory Factors in Pancreatic Cancer Cells.Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism.A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancerAnalytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues.Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.Stromal SPOCK1 supports invasive pancreatic cancer growth.A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.Energy sources identify metabolic phenotypes in pancreatic cancer.Metabolomics in pancreatic cancer biomarkers research.FOXO3 is essential for CD44 expression in pancreatic cancer cells.Long non-coding RNA CCAT1 that can be activated by c-Myc promotes pancreatic cancer cell proliferation and migration.Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma.A 25-gene classifier predicts overall survival in resectable pancreatic cancer.Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression.Estimation of metabolite networks with regard to a specific covariable: applications to plant and human data.High Expression of FAM83B Predicts Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma and Correlates with Cell Cycle and Cell Proliferation.Identification of potential erythrocyte phospholipid fatty acid biomarkers of advanced lung adenocarcinoma, squamous cell lung carcinoma, and small cell lung cancer.Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer.Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets.Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.A Landscape of Metabolic Variation across Tumor Types.
P2860
Q26768503-DA60F96B-8D6C-4796-9A66-6FE4CDA09580Q27022231-DED92B66-1B91-455F-B76E-BC145B4B6F53Q28543038-D0021E31-6F8D-403F-9B75-A630116E5BA9Q30945958-423721BC-12A6-404F-822C-5BE250A0E5FBQ31114185-6181D73F-8BBE-4AE0-8835-3C86B86FE00AQ33827703-D656DF9B-D950-464D-9491-ECFFEDFE2B06Q33890351-E38589E6-31D3-4A83-A2BB-8C374E074F5CQ34157807-B3DCA19B-8DDC-417C-85DF-7779D3EC1BCDQ34436487-B2BB0FFF-3313-470F-A1CF-10EC055EBBD4Q35149924-BD9F86B9-1AFB-471A-A445-494230D1091BQ35610559-5BDF6A99-F25D-447A-AFE7-88D382CCDB7CQ35766799-67B305E2-F9D8-48E0-836F-15588AB89A57Q35961180-1D70FCB4-BB61-48EC-990B-662100B11CF1Q36082169-15B05F41-DCA7-46C3-925D-E613DD3CD4A1Q36189152-886AC929-1A34-4789-AEA1-B681B83CA243Q36280853-702E55F0-1777-45E4-A828-E483BEC165EFQ36309665-2F55940B-38A7-44D8-AE03-C78497286903Q36344287-9117667D-3485-4633-9CB9-2311311F50DDQ36545666-1B448CC6-9486-45A1-8C25-D6BD03F6006BQ36604092-A34FCA3B-A68F-4B12-A759-8644DA3B0801Q37694765-BC0E3B36-D693-4015-B2B8-5424120C6434Q37706944-B426FDF5-FF80-4C68-91B3-F4CC6B41A313Q38235440-9F632EE5-165C-4C45-9372-DFFA0CDDB4B8Q38547110-60559DF7-2B9C-4A3A-ADC2-56A20AFDFE82Q38685933-7A468EEA-7985-4061-81C1-107F790406F3Q38863828-1E3C022F-A03D-43C7-A202-CD7723EA89E4Q38959840-92232D61-F9E3-48BE-A153-6DCD0AF44A4CQ38997162-09CB5EF6-6F61-4D93-93B1-8CA83C51CF12Q39148508-13283C53-5C62-41C7-8732-128A56877B01Q40634170-64458FAF-8CC2-45F4-A657-C47B4C5D390BQ41592795-1B80B978-19AF-44B4-87F3-C0E1E36100C6Q41711884-BACCC3F1-479D-489D-BF3B-A10A9DC3DD8EQ41811874-3FA7480A-57F4-474D-A914-91FDF9C7DEE8Q42362879-CF9344A4-33BA-4F31-95FA-512719E3F0C4Q45417541-00DD9172-D1D8-4618-A5D8-A8C391497741Q46769575-2B74D86D-87EB-447C-931B-8E6AFA9AE47DQ47128109-875F4B55-778A-48A5-95D2-67C4ACDC82B6Q47243883-EDDD018F-D7CE-4562-BB6A-52DE29720FD5Q47661469-65F43AAF-4BC0-4C84-8439-9C39DB8EE606Q49359410-E2041A6F-21AB-4EB6-B72C-34C290587158
P2860
Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Integration of metabolomics an ...... cts in human pancreatic cancer
@en
Integration of metabolomics an ...... ts in human pancreatic cancer.
@nl
type
label
Integration of metabolomics an ...... cts in human pancreatic cancer
@en
Integration of metabolomics an ...... ts in human pancreatic cancer.
@nl
prefLabel
Integration of metabolomics an ...... cts in human pancreatic cancer
@en
Integration of metabolomics an ...... ts in human pancreatic cancer.
@nl
P2093
P2860
P1476
Integration of metabolomics an ...... cts in human pancreatic cancer
@en
P2093
Anirban Maitra
Anuradha Budhu
B Michael Ghadimi
Dong H Lee
Geng Zhang
H Richard Alexander
Hanson Tan
Harris G Yfantis
Jochen Gaedcke
Nader Hanna
P2860
P304
P356
10.1158/1078-0432.CCR-13-0209
P407
P50
P577
2013-08-05T00:00:00Z